153 related articles for article (PubMed ID: 36343595)
21. Activation of minority-variant Plasmodium vivax hypnozoites following artesunate + amodiaquine treatment in a 23-year old man with relapsing malaria in Antananarivo, Madagascar.
Andrianaranjaka V; Lin JT; Golden C; Juliano JJ; Randrianarivelojosia M
Malar J; 2013 May; 12():177. PubMed ID: 23721298
[TBL] [Abstract][Full Text] [Related]
22. Plasmodium vivax malaria: status in the Republic of Korea following reemergence.
Park JW; Jun G; Yeom JS
Korean J Parasitol; 2009 Oct; 47 Suppl(Suppl):S39-50. PubMed ID: 19885334
[TBL] [Abstract][Full Text] [Related]
23. The burden of Plasmodium vivax relapses in an Amerindian village in French Guiana.
Nacher M; Stefani A; Basurko C; Lemonnier D; Djossou F; Demar M; Elenga N; Brousse P; Ville M; Carme B
Malar J; 2013 Oct; 12():367. PubMed ID: 24156660
[TBL] [Abstract][Full Text] [Related]
24. Declining Burden of
Chu CS; Carrara VI; Parker DM; Proux S; Charunwatthana P; McGready R; Nosten F
Am J Trop Med Hyg; 2020 Jan; 102(1):147-150. PubMed ID: 31746312
[TBL] [Abstract][Full Text] [Related]
25. Single nucleotide polymorphism analysis of pvmdr-1 in Plasmodium vivax isolated from military personnel of Republic of Korea in 2016 and 2017.
Bong JJ; Lee W; Lee CH; Park Q; Noh KT
Malar J; 2022 Jun; 21(1):205. PubMed ID: 35765071
[TBL] [Abstract][Full Text] [Related]
26. Plasmodium vivax malaria relapses at a travel medicine centre in Rio de Janeiro, a non-endemic area in Brazil.
Pedro RS; Guaraldo L; Campos DP; Costa AP; Daniel-Ribeiro CT; Brasil P
Malar J; 2012 Jul; 11():245. PubMed ID: 22839416
[TBL] [Abstract][Full Text] [Related]
27. Several Plasmodium vivax relapses after correct primaquine treatment in a patient with impaired cytochrome P450 2D6 function.
Martin Ramírez A; Lombardia González C; Soler Maniega T; Gutierrez Liarte Á; Domingo García D; Lanza Suárez M; Bernal Fernández MJ; Rubio JM
Malar J; 2020 Jul; 19(1):259. PubMed ID: 32680522
[TBL] [Abstract][Full Text] [Related]
28. A mathematical model for assessing the effectiveness of controlling relapse in Plasmodium vivax malaria endemic in the Republic of Korea.
Kim S; Byun JH; Park A; Jung IH
PLoS One; 2020; 15(1):e0227919. PubMed ID: 31978085
[TBL] [Abstract][Full Text] [Related]
29. Modeling the dynamics of Plasmodium vivax infection and hypnozoite reactivation in vivo.
Adekunle AI; Pinkevych M; McGready R; Luxemburger C; White LJ; Nosten F; Cromer D; Davenport MP
PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003595. PubMed ID: 25780913
[TBL] [Abstract][Full Text] [Related]
30. Modelling the contribution of the hypnozoite reservoir to Plasmodium vivax transmission.
White MT; Karl S; Battle KE; Hay SI; Mueller I; Ghani AC
Elife; 2014 Nov; 3():. PubMed ID: 25406065
[TBL] [Abstract][Full Text] [Related]
31. Epidemiology of Plasmodium vivax Malaria in India.
Anvikar AR; Shah N; Dhariwal AC; Sonal GS; Pradhan MM; Ghosh SK; Valecha N
Am J Trop Med Hyg; 2016 Dec; 95(6 Suppl):108-120. PubMed ID: 27708188
[TBL] [Abstract][Full Text] [Related]
32. Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites.
Imwong M; Snounou G; Pukrittayakamee S; Tanomsing N; Kim JR; Nandy A; Guthmann JP; Nosten F; Carlton J; Looareesuwan S; Nair S; Sudimack D; Day NP; Anderson TJ; White NJ
J Infect Dis; 2007 Apr; 195(7):927-33. PubMed ID: 17330781
[TBL] [Abstract][Full Text] [Related]
33. Quantifying and preventing Plasmodium vivax recurrences in primaquine-untreated pregnant women: An observational and modeling study in Brazil.
Corder RM; de Lima ACP; Khoury DS; Docken SS; Davenport MP; Ferreira MU
PLoS Negl Trop Dis; 2020 Jul; 14(7):e0008526. PubMed ID: 32735631
[TBL] [Abstract][Full Text] [Related]
34. Genotyping of Plasmodium vivax reveals both short and long latency relapse patterns in Kolkata.
Kim JR; Nandy A; Maji AK; Addy M; Dondorp AM; Day NP; Pukrittayakamee S; White NJ; Imwong M
PLoS One; 2012; 7(7):e39645. PubMed ID: 22808048
[TBL] [Abstract][Full Text] [Related]
35. Randomized, open-label trial of primaquine against vivax malaria relapse in Indonesia.
Sutanto I; Tjahjono B; Basri H; Taylor WR; Putri FA; Meilia RA; Setiabudy R; Nurleila S; Ekawati LL; Elyazar I; Farrar J; Sudoyo H; Baird JK
Antimicrob Agents Chemother; 2013 Mar; 57(3):1128-35. PubMed ID: 23254437
[TBL] [Abstract][Full Text] [Related]
36. Modeling Plasmodium vivax: relapses, treatment, seasonality, and G6PD deficiency.
Chamchod F; Beier JC
J Theor Biol; 2013 Jan; 316():25-34. PubMed ID: 22959914
[TBL] [Abstract][Full Text] [Related]
37. Biological concepts in recurrent Plasmodium vivax malaria.
Markus MB
Parasitology; 2018 Nov; 145(13):1765-1771. PubMed ID: 29564998
[TBL] [Abstract][Full Text] [Related]
38. Plasmodium vivax malaria among U.S. forces Korea in the Republic of Korea, 1993-2007.
Klein TA; Pacha LA; Lee HC; Kim HC; Lee WJ; Lee JK; Jeung GG; Sames WJ; Gaydos JC
Mil Med; 2009 Apr; 174(4):412-8. PubMed ID: 19485113
[TBL] [Abstract][Full Text] [Related]
39. UK malaria treatment guidelines.
Lalloo DG; Shingadia D; Pasvol G; Chiodini PL; Whitty CJ; Beeching NJ; Hill DR; Warrell DA; Bannister BA;
J Infect; 2007 Feb; 54(2):111-21. PubMed ID: 17215045
[TBL] [Abstract][Full Text] [Related]
40. Randomized trial of primaquine hypnozoitocidal efficacy when administered with artemisinin-combined blood schizontocides for radical cure of Plasmodium vivax in Indonesia.
Nelwan EJ; Ekawati LL; Tjahjono B; Setiabudy R; Sutanto I; Chand K; Ekasari T; Djoko D; Basri H; Taylor WR; Duparc S; Subekti D; Elyazar I; Noviyanti R; Sudoyo H; Baird JK
BMC Med; 2015 Dec; 13():294. PubMed ID: 26654101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
